IV Flush Syringe Market
Number of pages: 100 | Report Format: PDF | Published date: January 17, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 293.23 million |
|
Revenue Forecast in 2030 |
US$ 472.34 million |
|
CAGR |
5.40% |
|
Base Year for Estimation |
2021 |
|
Historical Year |
2020 |
|
Forecast Period |
2022-2030 |
|
Segments Covered |
Type, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global IV flush syringe market was valued at US$ 293.23 million in 2021 and is expected to register a revenue CAGR of 5.40% to reach US$ 472.34 million by 2030.
IV Flush Syringe Market Fundamentals
IV flush syringes are medical devices used to clear intravenous pathways and prevent blockage formation in veins. IV flush syringes clear the intravenous path so that every drop of medication reaches its active sites to get absorbed completely and help avoid drug mixing inside the tube. IV flush syringes are classified into saline and heparin. Saline IV flush syringe is used to clear and sterile the intravenous path for drug travel. A heparin IV flush syringe is an anticoagulant used before angioplasty and catheter insertion, which helps prevent blockage in arteries.
[465465498]
IV Flush Syringe Market Dynamics
The global IV flush syringe market is driven by increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, autoimmune disease, arthritis, and cancer. Additionally, rise in the need to avoid drug mixing, ensure patient safety, and implementation of stringent regulations associated with healthcare practices are fueling the global IV flush syringe market revenue growth.
However, increase in incidences of product recalls and lack of skilled professionals for the administration of IV flush syringes are hindering the revenue growth of the global IV flush syringe market.
IV Flush Syringe Market Ecosystem
The global IV Flush Syringe market is analyzed based on four parameters: type, application, end user, and region.
IV Flush Syringe Market by Type
[654312]
Based on the type, the global IV flush syringe market is segmented into saline IV flush syringes and heparin IV flush syringes.
The saline IV flush syringe segment dominates the global IV flush syringe market owing to high prevalence of chronic diseases, such as cardiovascular diseases, cancers, and arthritis. Furthermore, increasing patient hospitalization rates and multiple drug administration needs are also contributing to the revenue growth of the market. Additionally, the introduction of new products and high presence of key players manufacturing this product type are fueling the revenue growth in this segment.
IV Flush Syringe Market by Application
Based on the application, the global IV flush syringe market is segmented into cardiac diseases, rheumatoid arthritis, diabetes, cancer, and others.
The cancer segment accounts for the largest revenue share in the global IV flush syringe market owing to increasing prevalence of breast cancer and skin cancer. Additionally, increasing awareness about available cancer treatment solutions and rising need for immediate medical attention and hospitalization are driving revenue growth in the segment. In 2020, the National Cancer Institute stated that nearly 1,806,590 new cancer cases were likely to be diagnosed and 606,520 individuals were likely to die due to cancer in the U.S.
IV Flush Syringe Market by End User
Based on the end user, the global IV flush syringe market is segmented into hospitals, ambulatory surgical centers, clinics, and others.
The hospital segment dominates the global IV flush syringe market. This high revenue growth of the segment is attributed to increasing prevalence of chronic diseases, such as diabetes and cardiovascular diseases. Additionally, growing numbers of hospitals, improving healthcare practices, and rising number of product launches are contributing to the revenue growth of the global IV flush syringe market.
IV Flush Syringe Market by Region
Based on the region, the global IV flush syringe market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).
North America dominates the global IV flush syringe market in terms of revenue share. The large revenue share of North America in the global market can be attributed to increasing prevalence of cancer and cardiac diseases, developed infrastructure, and technological advancements in the region. Additionally, increasing adoption of standard healthcare practices and expanding healthcare infrastructure are contributing to the revenue growth in the North America IV flush syringe market.
IV Flush Syringe Market Competitive Landscape
The prominent players operating in the global IV flush syringe market are:
IV Flush Syringe Market Strategic Development/s
North America accounts for the largest revenue share in the global IV flush syringe market.
Growing prevalence of chronic diseases and increasing awareness about patient safety are fueling revenue growth in the global IV flush syringe market.
The global IV flush syringe market is expected register a revenue CAGR of 5.40% during the forecast period from 2022 to 2030.
The global IV flush syringe market is estimated to be valued at US$ 472.80 million in 2030.
Aquabiliti, B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, and Medefil, Inc. are among the key players operating in the global IV flush syringe market.
*Insights on financial performance are subject to the availability of information in the public domains*